Capital International LTD Vertex Pharmaceuticals Inc Transaction History

Capital International LTD

$2.19 Billion
Q1 2025

A detailed history of Capital International LTD transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Capital International LTD holds 112,546 shares of VRTX stock, worth $49.1 Million. This represents 2.49% of its overall portfolio holdings.

Number of Shares

112,546

Previous 110,571 1.79%

Holding current value

$49.1 Million

Previous $44.5 Million 22.54%

% of portfolio

2.49%

Previous 1.89%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$402.49 - $513.76 $794,917 - $1.01 Million	1,975 Added 1.79%	112,546 $54.6 Million
Q4 2024 Feb 13, 2025	BUY	$396.64 - $516.74 $4.35 Million - $5.67 Million	10,966 Added 11.01%	110,571 $44.5 Million
Q3 2024 Nov 13, 2024	SELL	$460.0 - $505.78 $398,360 - $438,005	-866 Reduced 0.86%	99,605 $46.3 Million
Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $359,421 - $444,259	915 Added 0.92%	100,471 $47.1 Million
Q1 2024 May 14, 2024	BUY	$407.69 - $446.08 $5.98 Million - $6.55 Million	14,680 Added 17.3%	99,556 $41.6 Million
Q4 2023 Feb 13, 2024	BUY	$343.0 - $410.68 $1.16 Million - $1.39 Million	3,377 Added 4.14%	84,876 $34.5 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $425,768 - $456,337	1,259 Added 1.57%	81,499 $28.3 Million
Q2 2023 Aug 11, 2023	BUY	$314.42 - $351.91 $3.31 Million - $3.7 Million	10,527 Added 15.1%	80,240 $28.2 Million
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $1.21 Million - $1.38 Million	4,258 Added 6.51%	69,713 $22 Million
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $1.54 Million - $1.73 Million	-5,395 Reduced 7.61%	65,455 $18.9 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $2.05 Million - $2.29 Million	7,483 Added 11.81%	70,850 $20.5 Million
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $26,080 - $32,473	111 Added 0.18%	63,367 $17.9 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $4.5 Million - $5.31 Million	-20,335 Reduced 24.33%	63,256 $16.5 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $1.78 Million - $2.24 Million	10,036 Added 13.64%	83,591 $18.4 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $2.26 Million - $2.53 Million	-12,473 Reduced 14.5%	73,555 $13.3 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $1.15 Million - $1.36 Million	6,144 Added 7.69%	86,028 $17.3 Million
Q1 2021 May 14, 2021	SELL	$207.02 - $241.31 $263,950 - $307,670	-1,275 Reduced 1.57%	79,884 $17.2 Million
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $225,847 - $301,214	-1,091 Reduced 1.33%	81,159 $19.2 Million
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $4.15 Million - $4.92 Million	16,221 Added 24.57%	82,250 $22.4 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $677,341 - $888,583	3,004 Added 4.77%	66,029 $19.2 Million
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $12.6 Million - $15.6 Million	63,025 New	63,025 $15 Million
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $1.15 Million - $1.32 Million	-6,831 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $116,138 - $135,458	797 Added 13.21%	6,831 $1.16 Million
Q1 2018 May 15, 2018	BUY	$151.6 - $177.13 $914,754 - $1.07 Million	6,034 New	6,034 $983,000

Others Institutions Holding VRTX

# of Institutions

1,830

Shares Held

233M

Call Options Held

1.38M

Put Options Held

1.08M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $112B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International LTD , based on Form 13F filings with the SEC.

News

Stay updated on Capital International LTD with notifications on news.

Account

Capital International LTD Vertex Pharmaceuticals Inc Transaction History